Abstract CT209: Correlation of robust local reactions prompting GM-CSF dose reduction to clinical response in a phase II trial of the AE37+GM-CSF HER2 peptide vaccine von Greene, Julia M., Schneble, Erika J., Litton, Jennifer K., Martin, Jonathon, Trappey, Alfred F., Berry, John S., Vreeland, Timothy J., Hale, Diane F., Clifton, Guy T., Ardavannis, Alexandros, Papamichail, Michael, Perez, Sonia, Ponniah, Sathibalan, Mittendorf, Elizabeth A., Peoples, George E.

Volltext